Nevertheless, Papachristos et al. and Panoilia et al. reported similar values of VEGF-A elimination half-life estimated using a population approach in metastatic cancer patients (5.97 and 1.73 days, respectively) [47,48]. Here, VEGFA is linked to metastatic malignant neoplasm.